| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1B | $2.9B | $2.5B | $2.2B | $0.5B | $0.4B | $0.4B | $0.4B |
| Cost of Revenue | — | — | — | — | $0.1B | $0.1B | $0.1B | $0.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.2B | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.7B | $1.5B | $1.4B | $1.2B | $0.3B | $0.2B | $0.2B | $0.2B |
| Net Income | $1.2B | $1.1B | $1.1B | $0.9B | $0.2B | $0.2B | $0.1B | $0.2B |
| EPS (Basic) | $15.72 | $14.09 | $14.45 | $10.78 | $2.35 | $1.89 | $1.45 | $1.75 |
| EPS (Diluted) | $15.69 | $14.05 | $14.39 | $10.72 | $2.32 | $1.87 | $1.44 | $1.70 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.7B | $5.4B | $5.5B | $5.0B | $5.5B | $4.2B | $4.2B | $3.4B |
| Current Assets | $1.6B | $1.3B | $1.4B | $1.7B | $2.1B | $1.9B | $2.1B | $1.4B |
| Cash & Equivalents | $0.5B | $0.4B | $0.5B | $1.0B | $1.4B | $1.3B | $1.5B | $0.9B |
| Total Liabilities | $8.4B | $6.4B | $6.3B | $6.0B | $5.7B | $4.6B | $4.3B | $3.6B |
| Current Liabilities | $1.8B | $1.6B | $1.5B | $1.3B | $1.3B | $1.0B | $0.9B | $0.8B |
| Stockholders' Equity | $-2.7B | $-0.9B | $-0.7B | $-1.0B | $-0.2B | $-0.4B | $-0.1B | $-0.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.5B | $1.2B | $1.1B | $0.9B | $0.8B | $0.7B | $0.6B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.8B | $-0.1B | $-1.0B | $-0.2B | $-0.1B | $0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.4B | $-1.4B | $-1.0B | $-1.4B | $0.2B | $-0.8B | $-0.0B | $-0.6B |